Apoptosis and impairment of neurite network by short exposure of immature rat cortical neurons to unconjugated bilirubin increase with cell differentiation and are additionally enhanced by an inflammatory stimulus

Journal of Neuroscience Research

Volumn 85, Issue 6, 2007, Pages 1229-1239

  Falcão, Ana S ^a   Silva, Rui F M ^a   Pancadas, Sérgio ^a   Fernandes, Adelaide ^a   Brito, Maria A ^a   Brites, Dora ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

Apoptosis; Inflammation; Long term neuronal abnormalities; Neurite outgrowth; Unconjugated bilirubin

Indexed keywords

BILIRUBIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN DEVELOPMENT; CELL DEATH; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; FETUS; INFLAMMATION; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NERVE FIBER GROWTH; NEURITE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BILIRUBIN; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EMBRYO; FEMALE; INFLAMMATION; LIPOPOLYSACCHARIDES; NERVE NET; NEURITES; NEURONS; PREGNANCY; RATS; RATS, WISTAR; TIME FACTORS;

EID: 34248141645     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21227     Document Type: Article

References (40)

1. Allan SM, Rothwell NJ. 2003. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 358:1669-1677.
2. American Academy of Pediatrics. 2004. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297-316.
3. Amit Y, Poznansky MJ, Schiff D. 1989. Bilirubin toxicity in a neuroblastoma cell line N-115: II. Delayed effects and recovery. Pediatr Res 25:369-372.
4. Benitez-King G, Ramirez-Rodriguez G, Ortiz L, Meza I. 2004. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Curr Drug Targets CNS Neurol Disord 3:515-533.
5. Berger GE, Wood S, McGorry PD. 2003. Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacol Bull 37:79-101.
6. Blanckaert N, Fevery J. 1990. Physiology and pathophysiology of bilirubin metabolism. In: Zakim D, Boyer TD, editors. Hepatology. A text book of liver disease. Philadelphia: WB Saunders Company. p 254-302.
7. Brito MA, Brites D, Butterfield DA. 2004. A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Res 1026:33-43.
8. Brito MA, Silva RFM, Brites D. 2006. Cell response to hyperbilirubinemia: a journey along key molecular events. In: Chen FJ, editor. New trends in brain research. New York: Nova Science Publishers, Inc. p 1-38.
9. Chen Y, Ghosh A. 2005. Regulation of dendritic development by neuronal activity. J Neurobiol 64:4-10.
10. Dalman C, Cullberg J. 1999. Neonatal hyperbilirubinemia - a vulnerability factor for mental disorder? Acta Psychiatr Scand 100:469-471.
11. Dennery PA, Seidman DS, Stevenson DK. 2001. Neonatal hyperbilirubinemia. N Engl J Med 344:581-590.
12. Falcão AS, Fernandes A, Brito MA, Silva RFM, Brites D. 2005. Bilirubin-induced inflammatory response, glutamate release, and cell death in rat cortical astrocytes are enhanced in younger cells. Neurobiol Dis 20:199-206.
13. Falcão AS, Fernandes A, Brito MA, Silva RFM, Brites D. 2006. Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state. Acta Neuropathol 112:95-105.
14. Fernandes A, Silva RFM, Falcão AS, Brito MA, Brites D. 2004. Cytokine production, glutamate release and cell death in rat cultured astrocytes treated with unconjugated bilirubin and LPS. J Neuroimmunol 153:64-75.
15. Gilmore JH, Fredrik JL, Vadlamudi S, Lauder JM. 2004. Prenatal infection and risk for schizophrenia: IL-1β, IL-6, and TNFα inhibit cortical neuron dendrite development. Neuropsychopharmacology 29:1221-1229.
16. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. 2006. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 81:47-63.
17. Gordo AC, Falcão AS, Fernandes A, Brito MA, Silva RFM, Brites D. 2006. Unconjugated bilirubin activates and damages microglia. J Neurosci Res 84:194-201.
18. Grojean S, Koziel V, Vert P, Daval JL. 2000. Bilirubin induces apoptosis via activation of NMDA receptors m developing rat brain neurons. Exp Neurol 166:334-341.
19. Hammond C. 2001. Neuron-glial cell cooperation. In: Hammond C, editor. Cellular and molecular neurobiology. London: Academic Press. p 24-35.
20. Hankø E, Hansen TWR, Almaas R, Lindstad J, Rootwelt T. 2005. Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr Res 57:179-184.
21. Hansen TWR. 2002. Mechanisms of bilirubin toxicity: clinical implications. Clin Perinatol 29:765-78.
22. Kaufmann WE, Moser HW. 2000. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 10:981-991.
23. Keshavan P, Schwemberger SJ, Smith DL, Babcock GF, Zucker SD. 2004. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer 112:433-445.
24. Mattson MP, Keller JN, Begley JG. 1998. Evidence for synaptic apoptosis. Exp Neurol 153:35-48.
25. McDonagh AF. 1979. Bile pigments: bilatrienes and 5,15-biladienes. In: Dolphin D, editor. The porphyrins. Vol. VI. San Diego, CA: Academic Press, p 293-491.
26. Miyaoka T, Seno H, Itoga M, Iijima M, Inagaki T, Horiguchi J. 2000. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J Clin Psychiatry 61:868-871.
27. Muller N, Schiller P, Ackenheil M. 1991. Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 24:225-228.
28. Ostrow JD, Pascolo L, Brites D, Tiribelli C. 2004. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med 10:65-70.
29. Peterson BS. 2003. Brain imaging studies of the anatomical and functional consequences of preterm birth for human brain development. Ann NY Acad Sci 1008:219-237.
30. Ramakers GJ. 2002. Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci 25:191-199.
31. Rigato I, Ostrow JD, Tiribelli C. 2005. Bilirubin and the risk of common non-hepatic diseases. Trends Mol Med 11:277-283.
32. Rothwell NJ. 1999. Cytokines - killers in the brain? J Physiol 514:3-17.
33. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. 1991. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics 88:828-833.
34. Shapiro SM. 2005. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 25:54-59.
35. Silva RFM, Rodrigues CMP, Brites D. 2001. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J Hepatol 34:402-408.
36. Silva RFM, Rodrigues CMP, Brites D. 2002. Rat cultured neuronal and glial cells respond differently to toxicity of unconjugated bilirubin. Pediatr Res 51:535-541.
37. Silva RFM, Falcão AS, Fernandes A, Gordo AC, Brito MA, Brites D. 2006. Dissociated primary nerve cell cultures as models for assessment of neurotoxicity. Toxicol Lett 163:1-9.
38. Yao JK, Reddy R, van Kammen DP. 2000. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Res 97:137-151.
39. Zhang L, Liu W, Tanswell AK, Luo X. 2003. The effects of bilirubin on evoked potentials and long-term potentiation in rat hippocampus in vivo. Pediatr Res 53:939-944.
40. Zucker SD, Horn PS, Sherman KE. 2004. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 40:827-835.